Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type

general

A biologic subset of diffuse large B-cell lymphomas with a unique molecular signature or expression profile. It represents approximately 50% of diffuse large B-cell lymphomas, and is characterized by the expression of CD10, BCL-6, A-myb, and LMO2 genes, BCL-2 translocation, and c-REL amplification. Morphologically, the vast majority of these lymphomas are centroblastic and a small minority are immunoblastic (ratio20:1). Patients with this type of diffuse large B-cell lymphoma have a more favo

40

Centers

55

Active Trials

$812M

Cancer Funding

Specific Cancer Types(2)

Top Centers for Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type(40)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
64.5
2
NCI Comprehensive
Active Research Program
64.5
3
NCI Comprehensive
Active Research Program
64.5
4
NCI Comprehensive
Active Research Program
64.5
5
NCI Comprehensive
Active Research Program
64.5
664.5
7
NCI Comprehensive
Active Research Program
64.5
8
NCI Comprehensive
Active Research Program
64.5
9
NCI Comprehensive
Active Research Program
64.5
10
NCI Comprehensive
Active Research Program
64.5
11
NCI Comprehensive
Active Research Program
64.5
12
Active Research Program
64.5
13
Active Research Program
64.5
14
Active Research Program
64.5
15
Active Research Program
64.5
16
NCI Comprehensive
42.0
17
NCI Comprehensive
42.0
18
NCI Comprehensive
42.0
19
NCI Comprehensive
42.0
20
NCI Comprehensive
42.0
21
NCI Comprehensive
42.0
22
NCI Comprehensive
42.0
23
NCI Comprehensive
42.0
24
NCI Comprehensive
42.0
2542.0
26
Cedars-Sinai CancerLos Angeles, CA
42.0
27
NCI Comprehensive
42.0
2842.0
2942.0
30
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
42.0
3142.0
3242.0
3342.0
3442.0
3542.0
3642.0
37
NCI Comprehensive
38
39
40

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →